BioSpace News Archive

MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced today that the United States Patent and Trademark Office has issued US Patent 10,360,349 covering its Precision Medicine Service for use by hospitals, pharmaceutical companies, laboratories, health information systems and the broader clinical informatics industry.

Capturing objective data in about five seconds that can aid concussion diagnoses through an iPhone, the Reflex PLR Analyzer, an industry-disruptive diagnostic tool for traumatic brain injury (TBI) and various cognitive issues, is rapidly advancing in the healthcare market

West Coast Venture Group, Corp. (WCVC) (“WCVC”) would like to take this opportunity to discuss the lab results from Illegal Brands CBD.

Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has received approval from the U.S. government and successfully imported an initial shipment of medical cannabinoids into the U.S. to support two clinical trials led by NYU School of Medicine.

Meitheal Pharmaceuticals (“Meitheal”), a fully integrated generic injectables company based in Chicago, Illinois today announced that Hong Kong King-Friend Industrial Company, a wholly-owned subsidiary of China-based manufacturer Nanjing King-Friend Biochemical Pharmaceutical Company (NKF), has agreed to take an increased stake in the business for US$95 million

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today reported financial results for the second quarter ended June 30, 2019.

Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday, September 16, 2019 at 2:00 p.m. Central Time.

Profusa, an empowered health company that is pioneering the next generation of personalized medicine, today announced in collaboration with RTI International and Duke University the award of a DARPA (Defense Advanced Research Projects Agency) award to develop an early identification system to detect disease outbreaks, biological attacks and pandemics up to three weeks earlier than current methods.

The global atherosclerosis therapeutics market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio.

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, reported financial results for the second calendar quarter of 2019.